Form 4: Protagonist Therapeutics Chief Medical Officer Executes Stock Option and Sells Shares

Protagonist Therapeutics' Chief Medical Officer, Arturo Molina, exercised stock options and sold shares in multiple transactions over two days.

Summary

• Arturo Molina, Chief Medical Officer of Protagonist Therapeutics, exercised stock options to acquire a total of 31,529 shares of common stock at a price of $8.04 per share.
• He then sold the same number of shares in multiple transactions at weighted average prices ranging from $44.50 to $45.60 per share.
• These transactions occurred on November 26 and 27, 2024.
• Following these transactions, Mr. Molina still beneficially owns 46,444 shares of common stock and has options to purchase 95,971 shares.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to exercise stock options and sell shares, especially after vesting periods.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice across the biotechnology industry.
• The reported prices are within the typical range for stock transactions by company insiders.
• Similar filings are regularly made by executives at comparable companies such as BioMarin Pharmaceutical and Vertex Pharmaceuticals.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the volume of shares sold.
• Shareholders may view this as a positive sign of executive confidence in the company's future, as the executive is exercising options.

Key Dates

Keywords

stock options, insider trading, share sales, common stock, Protagonist Therapeutics, PTGX, executive compensation